Page 494 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 494
Chapter 30 Aplastic Anemia 414.e1
REFERENCES 16. Bacigalupo A: Bone marrow transplantation for acquired severe aplastic
anemia. Hematol Oncol Clin North Am 28:1145–1155, 2014.
1. Scheinberg P, Young NS: How I treat aplastic anemia. Blood 120:1185, 17. Schrezenmeier H, Passweg JR, Marsh JCW, et al: Worse outcome and
2012. more chronic GVHD with peripheral blood progenitor cells than bone
2. Kaufman DW, Kelly JP, Levy M, et al: The drug etiology of agranulocytosis marrow in HLA-matched sibling donor tranplants for young patients
and aplastic anemia, New York, 1991, Oxford. with severe aplastic anemia. Blood 110:1397–1400, 2007.
3. Issaragrisil S, Kaufman D, Anderson T, et al: The epidemiology of 18. Locasciulli A, Oneto R, Bacigalupo A, et al: Outcome of patients with
aplastic anemia in Thailand. Blood 107:1299–1307, 2006. acquired aplastic anemia given first line bone marrow transplantation or
4. Townsley DM, Dumitriu B, Young NS: Bone marrow failure and the immunosuppressive treatment in the last decade: a report from the Euro-
telomeropathies. Blood 124:2775–2783, 2014. pean Group for Blood and Marrow Transplantation. Haematologica
5. Dokal I, Vulliamy T: Inherited aplastic anaemias/bone marrow failure 92:11–18, 2007.
syndromes. Blood Rev 40:719–722, 2008. 19. Bacigalupo A, Socie G, Hamladji RM, et al: Current outcome of HLA
6. Maciejewski JP, Selleri C, Tadatsugu S, et al: A severe and consistent identical sibling vs. unrelated donor transplants in severe aplastic anemia:
deficit in marrow and circulating primitive hematopoietic cells an EBMT analysis. Haematologica 100:696–702, 2015.
(long-term culture-initiating cells) in acquired aplastic anemia. Blood 20. Horowitz MM: Current status of allogeneic bone marrow transplanta-
88:1983–1991, 1996. tion in acquired aplastic anemia. Semin Hematol 37:30–42, 2000.
7. Scheinberg P, Chen J: Aplastic anemia: what have we learned from animal 21. Passweg JR, Marsh JC: Aplastic anemia: first-line treatment by immu-
models and from the clinic. Semin Hematol 50:156–164, 2013. nosuppression and sibling marrow transplantation. Hematology Am Soc
8. Kopolovic I, Ostro J, Tsubota H, et al: A systematic review of transfusion- Hematol Educ Program 2010:36–42, 2010.
associated graft-versus-host disease. Blood 126:406–414, 2015. 22. Aderka D, Praff G, Santo M, et al: Bleeding due to thrombocytopenia in
9. Brown KE, Tisdale J, Dunbar CE, et al: Hepatitis-associated aplastic acute leukemias and reevaluation of the prophylactic platelet transfusion
anemia. N Engl J Med 336:1059–1064, 1997. policy. Am J Med Sci 291:147–151, 1986.
10. Afable MG, Wlodarski M, Makishima H, et al: SNP array-based 23. de Peffault LR, Purtill D, Ruggeri A, et al: Influence of nucleated cell
karyotyping: differences and similarities between aplastic anemia and dose on overall survival of unrelated cord blood transplantation for
hypocellular myelodysplastic syndromes. Blood 117:6876–6884, 2011. patients with severe acquired aplastic anemia: a study by eurocord and
11. Yoshizato T, Dumitriu B, Hosokawa K, et al: Somatic mutations and the aplastic anemia working party of the European group for blood and
clonal hematopoiesis in aplastic anemia. N Engl J Med 373:35–47, 2014. marrow transplantation. Biol Blood Marrow Transplant 17:78–85, 2011.
12. Valdez JM, Scheinberg P, Nunez O, et al: Decreased infection-related 24. Sanders JE, Woolfrey AE, Carpenter PA, et al: Late effects among
mortality and improved survival in severe aplastic anemia in the past pediatric patients followed for nearly 4 decades after transplantation for
two decades. Clin Infect Dis 52:726–735, 2011. severe aplastic anemia. Blood 118:1421–1428, 2011.
13. Leitman SF, Oblitas JM, Emmons R, et al: Clinical efficacy of daily 25. Scheinberg P, Nunez O, Weinstein B, et al: Horse versus rabbit antithy-
G-CSF-recruited granulocyte transfusions in patients with severe neutro- mocyte globulin in acquired aplastic anemia. N Engl J Med 365:430–438,
penia and life-threatening infections [abstract]. Blood 88(Suppl 1):331a, 2011.
1996. 26. Scheinberg P, Cooper JN, Sloand EM, et al: Association of telomere
14. Tichelli A, Passweg JR: Matched sibling donor hematopoietic stem cell length of peripheral blood leukocytes predicts hematopoietic relapse,
transplant in patients with acquired aplastic anemia. Curr Drug Targets malignant transformation, and survival in severe aplastic anemia. JAMA
2016. in press. 304:1358–1364, 2010.
15. Miano M, Dufour C: The diagnosis and treatment of aplastic anemia: a 27. Townsley DM, Bogdan D, Delong L, et al: Danazol treatment for
review. Int J Hematol 101:527–535, 2015. telomere diseases. N Engl J Med 374:1922–1931, 2016.

